… bleeding, minor bleeding, IS and SE for rivaroxaban, relative risk of intracranial bleeding,
minor bleeding and IS for warfarin and utility value for stable patients on other therapy. …

… clinical outcomes of patients with atrial fibrillation (AF). … This study assessed the expected
cost-effectiveness of applying … The exploration suggested the potential cost-effective use of …

… and respiratory support in patients who have suffered cardiac arrest. In this study, we
investigated the cost-utility of ECPR (cost/QALY) in cardiac arrest patients treated at our institution. …

… in patients with non-valvular atrial fibrillation (NVAF) in the US and Europe. This study assessed
the cost-… Baseline utilities were calculated by multiplying utility weights for all well-based …

… Utility weights range from 0 to 1, with 0 representing death, 1 representing perfect health …
for patients with a given condition. Utility weights for patients with ongoing atrial fibrillation as …

… in the cost-effectiveness analysis was QALYs gained (cost-utility analysis). … in utility due
to the presence of the AF disease compared to those without AF was applied to all AF patients, …

… a robust first picture of the cost-utility of increasing PCI use in elderly ACS patients. Second,
the study population may not reflect current ACS patients and practice. While PCI rate and in-…

… patients with atrial fibrillation (AF) remain unclear. This study aimed to estimate and compare
the cost-… Other model inputs, including the utilities and the costs, were all estimated from …

… The parametric functions applied were the beta distribution for utilities, the gamma distribution
for costs and the HR of death and the log-normal distribution for the HR of clinical events. …

… Cost-utility analysis is a form of cost-… costs, direct nonmedical costs, and indirect costs of
patients who had ischemic stroke and AF and taking warfarin or rivaroxaban to compare cost-…